enVVeno Medical (NASDAQ:NVNO) Releases Earnings Results

enVVeno Medical (NASDAQ:NVNO) issued its quarterly earnings data on Thursday. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.35) by $0.05, Zacks reports.

enVVeno Medical Trading Down 9.9 %

enVVeno Medical stock traded down $0.35 during mid-day trading on Friday, hitting $3.18. The company had a trading volume of 239,342 shares, compared to its average volume of 111,170. The company has a market capitalization of $55.76 million, a price-to-earnings ratio of -2.47 and a beta of 1.22. enVVeno Medical has a 12-month low of $2.45 and a 12-month high of $6.97. The company’s fifty day moving average is $3.27 and its 200-day moving average is $3.70.

enVVeno Medical Company Profile

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).